IFITM3 expression in B-cell progenitors and Ph+ acute lymphoblastic leukemia (ALL) cells stabilizes CD19 membrane expression, which affects cell proliferation through positive IL7R regulation and limits the activity of BCR-ABL1 (13). Here, IFITM3 is linked to acute lymphoblastic leukemia.